Measurement limitations and other factors confound determination of endothelial cell loss after endothelial keratoplasty

Measurement limitations and other factors confound determination of endothelial cell loss after endothelial keratoplasty
Endothelial cell loss after endothelial keratoplasty could be due to surgical handling, but in fact may be overestimated for a variety of reasons, said Isabel Dapena, MD, PhD, at the 5th EuCornea Congress. “Since endothelial cell loss in endothelial keratoplasty has generally been attributed to donor tissue manipulation during surgery, when DMEK became a standardized ‘no touch’ technique, we expected it would be associated with a lower endothelial cell loss rate than DSAEK. To our surprise, there was no difference,” said Dr. Dapena, cornea specialist, Melles CorneaClinic, Netherlands Institute for Innovative Ocular Surgery, Rotterdam, The Netherlands. “Therefore, we considered there must be factors other than tissue handling that may be affecting our measurements.” Outlining the possible contributors, Dr. Dapena noted that there are limitations introduced by the measurement techniques. Cell counting techniques used in eye banks generally lead to overestimation of the preoperative donor endothelial cell density, she said. In addition, the in vivo postoperative measurements are performed by a different observer using different methodology and different instrumentation.        
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...